Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
Exercise and cardiovascular benefit in subjects with COPD: the need for randomised trials Source: Eur Respir J 2014; 44: 263-264 Year: 2014
Exercise and cardiovascular benefit in subjects with COPD: the need for randomised trials Source: Eur Respir J 2014; 44: 264-265 Year: 2014
Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx) Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020
Run-in bias in randomised trials: the case of COPD medications Source: Eur Respir J, 49 (6) 1700361; 10.1183/13993003.00361-2017 Year: 2017
Risk factors for discontinuation of roflumilast in COPD patients Source: International Congress 2017 – COPD management Year: 2017
Risk factors for COPD Source: Eur Respir J 2006; 28: Suppl. 50, 448s Year: 2006
Risk scores for predicting death in COPD patients Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016
Roflumilast for stable COPD: Meta-analysis of randomized controlled trials Source: International Congress 2014 – Clinical presentations Year: 2014
Risk of non-lower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT trial Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010
COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study Source: International Congress 2014 – Markers Year: 2014
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019 Year: 2019
Risk of stroke in COPD: a matched cohort study Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017
Factors associated with mortality in the TORCH trial in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 356s Year: 2007
Risk factors for mortality in patients with COPD exacerbation Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009
Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018 Year: 2019
Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013
Laboratory and clinical parameters in predicting risk of future exacerbations in both non-smoking and smoking COPD patients Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014